跳至主要内容
临床试验/KCT0004515
KCT0004515招募中未知

Development of a new immunochemistry method using antibodies of ARS group and AIMP2-DX2 in the pancreatic cancer cell

Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 90(Year)(—)
性别
All

入选标准

  • 1. Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET-CT)
  • 2. Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
  • 3. Patients who underwent surgical treatment with pancreatic cancer

排除标准

  • 1. Minors under the age of 19, vulnerable subjects such as illiteracy
  • 2. Excludes necrotic specimens

研究者

发起方
Yonsei University Health System, Gangnam Severance Hospital

相似试验